Cargando…

Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis

With targeted treatments playing an increasing role in oncology, the need arises for fast non-invasive genotyping in clinical practice. Radiogenomics is a rapidly evolving field of research aimed at identifying imaging biomarkers useful for non-invasive genotyping. Radiogenomic genotyping has the ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jansen, Robin W., van Amstel, Paul, Martens, Roland M., Kooi, Irsan E., Wesseling, Pieter, de Langen, Adrianus J., Menke-Van der Houven van Oordt, Catharina W., Jansen, Bernard H.E., Moll, Annette C., Dorsman, Josephine C., Castelijns, Jonas A., de Graaf, Pim, de Jong, Marcus C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929452/ https://www.ncbi.nlm.nih.gov/pubmed/29732009 http://dx.doi.org/10.18632/oncotarget.24893

Ejemplares similares

A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression
por: Kooi, Irsan E., et al.
Publicado: (2016)

Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression
por: Kooi, Irsan E., et al.
Publicado: (2015)

Successful Trastuzumab-Deruxtecan Rechallenge After Interstitial Lung Disease: A Case Report
por: de Weger, Vincent A., et al.
Publicado: (2023)

[(18)F]FES uptake in the pituitary gland and white matter of the brain
por: Iqbal, R., et al.
Publicado: (2021)

Treatment with somatostatin analogues and PRRT in metastatic middle ear adenoma with neuroendocrine features
por: Lima Ferreira, Joana, et al.
Publicado: (2021)

Explainable artificial intelligence (XAI) in radiology and nuclear medicine: a literature review
por: de Vries, Bart M., et al.
Publicado: (2023)

High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures
por: Roohollahi, Khashayar, et al.
Publicado: (2022)

Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes
por: Kooi, Irsan E., et al.
Publicado: (2016)

Hepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?
por: van Prehn, Joffrey, et al.
Publicado: (2017)

Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis
por: van Helden, E. J., et al.
Publicado: (2017)

Optimal imaging time points considering accuracy and precision of Patlak linearization for (89)Zr-immuno-PET: a simulation study
por: Wijngaarden, Jessica E., et al.
Publicado: (2022)

The Prediction of Biological Features Using Magnetic Resonance Imaging in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: van der Hulst, Hedda J., et al.
Publicado: (2023)

Diagnostic Performance of [(18)F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer
por: Iqbal, Ramsha, et al.
Publicado: (2021)

MR Imaging Features to Differentiate Retinoblastoma from Coats’ Disease and Persistent Fetal Vasculature
por: Jansen, Robin W., et al.
Publicado: (2020)

Early (18)F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer
por: van Helden, Erik J., et al.
Publicado: (2016)

Systemic Therapy for Patients with HER2-Positive Breast Cancer and Brain Metastases: A Systematic Review and Meta-Analysis
por: Werter, Inge M., et al.
Publicado: (2022)

Potential and pitfalls of (89)Zr-immuno-PET to assess target status: (89)Zr-trastuzumab as an example
por: Huisman, Marc C., et al.
Publicado: (2021)

Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study
por: Mammatas, L. H., et al.
Publicado: (2020)

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
por: Jauw, Yvonne W. S., et al.
Publicado: (2016)

Radiomics analysis of pre-treatment [(18)F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
por: van Helden, E. J., et al.
Publicado: (2018)

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer
por: van Helden, Erik J., et al.
Publicado: (2019)

(89)Zr-cetuximab PET imaging in patients with advanced colorectal cancer
por: Menke-van der Houven van Oordt, Catharina Willemien, et al.
Publicado: (2015)

Radiogenomics of lung cancer
por: Wong, Chi Wah, et al.
Publicado: (2020)

Radiogenomics in Colorectal Cancer
por: Badic, Bogdan, et al.
Publicado: (2021)

Coregulation of FANCA and BRCA1 in human cells
por: Haitjema, Anneke, et al.
Publicado: (2014)

Noise sensitivity of (89)Zr-Immuno-PET radiomics based on count-reduced clinical images
por: Somasundaram, Ananthi, et al.
Publicado: (2022)

Cost-Utility of the eHealth Application ‘Oncokompas’, Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial
por: Schuit, Anouk S., et al.
Publicado: (2022)

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting
por: Bos, Manouk K., et al.
Publicado: (2023)

Radiomics and radiogenomics for precision radiotherapy
por: Wu, Jia, et al.
Publicado: (2018)

Radiogenomics and Radiomics in Liver Cancers
por: Saini, Aman, et al.
Publicado: (2018)

Precision Medicine in Radiomics and Radiogenomics
por: Monti, Serena
Publicado: (2022)

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using (18)F-FES PET/CT imaging
por: Jager, Agnes, et al.
Publicado: (2020)

Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma
por: Strijbis, Victor I. J., et al.
Publicado: (2021)

STROGAR – STrengthening the Reporting Of Genetic Association studies in Radiogenomics
por: Kerns, Sarah L., et al.
Publicado: (2013)

Asynchronous pineoblastoma is more likely after early diagnosis of retinoblastoma: a meta‐analysis
por: de Jong, Marcus C., et al.
Publicado: (2021)

Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer
por: Dinis Fernandes, Catarina, et al.
Publicado: (2023)

Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors
por: Ismail, Marwa, et al.
Publicado: (2023)

Early Response Prediction of Multiparametric Functional MRI and (18)F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation
por: Martens, Roland M., et al.
Publicado: (2022)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body (18)F-Fluorodeoxyglucose and (89)Zr-Rituximab PET Scans
por: de Vries, Bart M., et al.
Publicado: (2022)

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images
por: Jauw, Yvonne W. S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jo2i5u3irqjkv1n3arjbskvggg